Publication Topic

Jacobellis M, Blaby-Haas C. Selective pressure responsible for pathway evolution of arsenic tolerance in bioenergy algae. Science Undergraduate Laboratory Internship (SULI) Presentations, Brookhaven National Laboratory, Upton, NY, 2021.

Rager JE, Auerbach SS, Chappell GA, Martin E, Thompson C, Fry RC. 2017. Benchmark dose modeling estimates of the concentrations of inorganic arsenic that induce changes to the neonatal transcriptome, proteome, and epigenome in a pregnancy cohort. Chem Res Toxicol 30(10):1911-1920; doi: 10.1021/acs.chemrestox.7b00221.

Rager J, Thompson C, Auerbach S, Fry R. Integrating genomic and epigenomic data into risk assessment applications through dose response modeling: Case study with prenatal arsenic exposure. Environmental Mutagenesis and Genomics Society, Kansas City, KS, September 2016.

Paustenbach DJ, Insley AL, Maskrey JR, Bare JL, Unice KM, Conrad VB, Iordanidis L, Reynolds DW, DiNatale KD, Monnot AD. 2016. Analysis of total arsenic content in California wines and comparison to various health risk criteria. Am J Enol Viticult 67(2):179–187; doi: 10.5344/ajev.2015.15041.

Boekelheide K, Blumberg B, Chapin RE, Cote I, Graziano JH, Janesick A, Lane R, Lilycrop K, Myatt L, States JC, Thayer KA, Waalkes MP, Rogers JM. 2012. Predicting later-life outcomes of early-life exposures. Environ Health Perspect 120:1353–1361; doi: 10.1289/ehp.1204934.

Mink PJ, Alexander DD, Barraj LM, Kelsh MA, Tsuji JS. 2008. Low-level arsenic exposure in drinking water and bladder cancer: A review and meta-analysis. Regul Toxicol Pharmacol 52(3):299–310.

Williams CW, Perry CS. Risk assessment for arsenic on indoor surfaces. Presented at the Society for Risk Analysis Annual Meeting, Boston, MA, December 2008.

Gonesbatt ME, Vega L, Salazar AM, Montero R, Guzman P, Blas J, … Kelsh MA, et al. 1997. Cytogenetic effects in human exposure to arsenic. Mutat Res 386(3):219–228; doi: 10.1016/s1383-5742(97)00009-4. PMID: 9219560.

Del Razo LM, Garcia–Vargas GG, Vargas H, Albores A, Gonesbatt ME, Montero R, Ostrosky–Wegman P, Kelsh MA, et al. 1997. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. Arch Toxicol 71(4):211–217; doi: 10.1007/s002040050378. PMID: 9101036.